J van den Dool1, M A J Tijssen2, J H T M Koelman3, R H H Engelbert4, B Visser5. 1. ACHIEVE Centre of Expertise, Faculty of Health, Amsterdam University of Applied Sciences, Amsterdam, The Netherlands; Department of Neurology, University Medical Centre Groningen, Groningen, The Netherlands; Department of Neurology, Academic Medical Center, Amsterdam, The Netherlands. 2. Department of Neurology, University Medical Centre Groningen, Groningen, The Netherlands. 3. Department of Neurology, Academic Medical Center, Amsterdam, The Netherlands. 4. ACHIEVE Centre of Expertise, Faculty of Health, Amsterdam University of Applied Sciences, Amsterdam, The Netherlands; Department of Rehabilitation, Academic Medical Center, Amsterdam, The Netherlands. 5. ACHIEVE Centre of Expertise, Faculty of Health, Amsterdam University of Applied Sciences, Amsterdam, The Netherlands. Electronic address: b.visser2@hva.nl.
Abstract
BACKGROUND: Cervical dystonia (CD) is characterized by involuntary muscle contractions causing abnormal postures and/or twisting movements of the head and neck. These motor symptoms can have a major impact on disability. Treatment with botulinum toxin injections aims to reduce motor symptoms, and therefore disability. Despite motor improvements, many patients still experience difficulties with performing daily life activities. To optimize treatment, other factors that determine disability should be identified. OBJECTIVE: To explore and identify clinical characteristics that relate to disability in CD. METHODS: Data on disability, severity of dystonia, anxiety, depression, pain and quality of life of 96 CD patients was analyzed with a principal component analysis (PCA). Multiple regression analysis was performed to determine which components derived from the PCA explain most of the variance in disability. RESULTS: PCA revealed five components (disability, psychiatric features, pain, physical function and severity of dystonia), explaining 74.4% of the variance in disability. Multivariate association between disability and the other components was statistically significant (R2 change 0.433, F change (4-86) = 22.39, p = .000). Psychiatric features had the largest contribution to disability (standardized beta = 0.555, p = 0.000) followed by pain (standardized beta = 0.232 p = 0.004). Physical functioning (standardized beta = 0.059 p = 0.507) and severity of dystonia (standardized beta = -0.001 p = 0.991) had no significant contribution. CONCLUSIONS: In CD patients, psychiatric features and pain are important determinants of disability. Interventions to reduce psychiatric problems and pain should have a more prominent role in the treatment of CD patients in order to improve disability levels.
BACKGROUND: Cervical dystonia (CD) is characterized by involuntary muscle contractions causing abnormal postures and/or twisting movements of the head and neck. These motor symptoms can have a major impact on disability. Treatment with botulinum toxin injections aims to reduce motor symptoms, and therefore disability. Despite motor improvements, many patients still experience difficulties with performing daily life activities. To optimize treatment, other factors that determine disability should be identified. OBJECTIVE: To explore and identify clinical characteristics that relate to disability in CD. METHODS: Data on disability, severity of dystonia, anxiety, depression, pain and quality of life of 96 CDpatients was analyzed with a principal component analysis (PCA). Multiple regression analysis was performed to determine which components derived from the PCA explain most of the variance in disability. RESULTS: PCA revealed five components (disability, psychiatric features, pain, physical function and severity of dystonia), explaining 74.4% of the variance in disability. Multivariate association between disability and the other components was statistically significant (R2 change 0.433, F change (4-86) = 22.39, p = .000). Psychiatric features had the largest contribution to disability (standardized beta = 0.555, p = 0.000) followed by pain (standardized beta = 0.232 p = 0.004). Physical functioning (standardized beta = 0.059 p = 0.507) and severity of dystonia (standardized beta = -0.001 p = 0.991) had no significant contribution. CONCLUSIONS: In CDpatients, psychiatric features and pain are important determinants of disability. Interventions to reduce psychiatric problems and pain should have a more prominent role in the treatment of CDpatients in order to improve disability levels.
Authors: Bettina Balint; Niccolò E Mencacci; Enza Maria Valente; Antonio Pisani; John Rothwell; Joseph Jankovic; Marie Vidailhet; Kailash P Bhatia Journal: Nat Rev Dis Primers Date: 2018-09-20 Impact factor: 52.329
Authors: Abhimanyu Mahajan; Joseph Jankovic; Laura Marsh; Achint Patel; H A Jinnah; Cynthia Comella; Richard Barbano; Joel Perlmutter; Neepa Patel Journal: J Neurol Date: 2018-03-22 Impact factor: 4.849
Authors: Lisa Klingelhoefer; Kallol R Chaudhuri; Christoph Kamm; Pablo Martinez-Martin; Kailash Bhatia; Anna Sauerbier; Maximilian Kaiser; Carmen Rodriguez-Blazquez; Bettina Balint; Robert Untucht; Lynsey J Hall; Lauritz Mildenstein; Miriam Wienecke; Davide Martino; Olaf Gregor; Alexander Storch; Heinz Reichmann Journal: Ann Clin Transl Neurol Date: 2019-09-27 Impact factor: 4.511
Authors: Melanie Leigh Supnet; Patrick Acuna; Samuel J Carr; Jan Kristoper de Guzman; Xena Al Qahtani; Trisha Multhaupt-Buell; Taylor Francoeur; Gabrielle E Aldykiewicz; Priyanka R Alluri; Lindsey Campion; Lisa Paul; Laurie Ozelius; Ellen B Penney; Christopher D Stephen; Marisela Dy-Hollins; Nutan Sharma Journal: Front Neurol Date: 2020-11-27 Impact factor: 4.003
Authors: Lejla Paracka; Florian Wegner; Claus Escher; Martin Klietz; Martina de Zwaan; Mahmoud Abdallat; Assel Saryyeva; Joachim K Krauss Journal: Brain Sci Date: 2020-07-28